| Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations. (NCT01395589) | Hamad Medical Corporation | 2011-02-01 |
| A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge (NCT01299467) | Pfizer | 2011-02-01 |
| The Effect of Vitamin D Replacement on Airway Reactivity, Allergy and Inflammatory Mediators in Exhaled Breath Condensate in Vitamin D Deficient Asthmatic Children (NCT01287455) | Rambam Health Care Campus | 2011-02-01 |
| Prevalence and Reversibility of Lung Hyperinflation in Asthma (NCT01573364) | Chiesi Farmaceutici S.p.A. | 2011-02-01 |
| Qvar vs FP in Pediatrics (NCT01877954) | Research in Real-Life Ltd | 2011-02-01 |
| Orthomolecular Therapy and Asthma in Children (NCT00672529) | Canadian Institute of Natural and Integrative Medicine | 2011-02-01 |
| Reduce IDentified UNcontrolled Asthma (NCT01449409) | Kaiser Permanente | 2011-02-01 |
| TC-6987 for the Treatment of Mild to Moderate Asthma (NCT01296087) | Targacept Inc. | 2011-02-01 |
| A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin (NCT01411111) | GlaxoSmithKline | 2011-01-06 |
| Identification of Asthma Phenotypes in Severe Asthmatics (NCT01623089) | Singapore General Hospital | 2011-01-02 |
| Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma (NCT01277523) | Boehringer Ingelheim | 2011-01-01 |
| Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 2 (NCT01224951) | Universitaire Ziekenhuizen KU Leuven | 2011-01-01 |
| MRI for Non-Invasive Imaging in Neonates and Children (NCT02163681) | University of Virginia | 2011-01-01 |
| To Investigate the Effects of AZD1981 on the QT Interval (NCT01265641) | AstraZeneca | 2011-01-01 |
| The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids on p38 MAPK in Asthma (NCT01266434) | Mahidol University | 2011-01-01 |
| Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management (NCT01908075) | Research in Real-Life Ltd | 2011-01-01 |
| Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids (NCT01449162) | AB Science | 2011-01-01 |
| Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and Rhinitis (NCT01230437) | University of Aberdeen | 2011-01-01 |
| Online Asthma Self-Management for Children Aged 5-10 and Their Parents (NCT02602392) | Oregon Center for Applied Science, Inc. | 2011-01-01 |
| Motivational Intervention for Asthma (NCT01381159) | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 2011-01-01 |
| Asthma Inflammation Research (NCT01536522) | The Cleveland Clinic | 2011-01-01 |
| Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma (NCT01241006) | Alameda County Medical Center | 2011-01-01 |
| ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment) (NCT01475045) | Elpen Pharmaceutical Co. Inc. | 2011-01-01 |
| Novel Endpoints in Cough Challenge Testing (NCT01566968) | Manchester University NHS Foundation Trust | 2011-01-01 |
| A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma (NCT01334853) | MedImmune LLC | 2011-01-01 |
| The Role of Epigenetics in Inner City Asthma (NCT01382836) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-01-01 |
| Impact of Adherence to Treatment in Asthma Control (NCT01455545) | Sociedad Española de Neumología y Cirugía Torácica | 2011-01-01 |
| Determinants Of Oral Corticosteroid Responsiveness in Wheezing Asthmatic Youth (NCT02013076) | St. Justine's Hospital | 2011-01-01 |
| A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1) (NCT01245426) | GlaxoSmithKline | 2010-12-01 |
| Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma (NCT01238861) | MedImmune LLC | 2010-12-01 |
| Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma (NCT01257230) | Boehringer Ingelheim | 2010-12-01 |
| Vitamin and Asthma Study (NCT01447173) | Augusta University | 2010-12-01 |
| Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS (NCT01255709) | Amphastar Pharmaceuticals, Inc. | 2010-12-01 |
| Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg (NCT01256086) | MEDA Pharma GmbH & Co. KG | 2010-12-01 |
| Non-interventional Retrospective Multicenter Study of Patients With Bronchial Asthma During a Routine Visit to Out of Patients' Clinics (NCT01273363) | AstraZeneca | 2010-12-01 |
| Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma (NCT01269437) | NovaMed Pharmaceuticals Inc. | 2010-12-01 |
| Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma (NCT01248975) | GlaxoSmithKline | 2010-12-01 |
| To Evaluate the Use of ASTHMA IQ in a Primary Care Setting (NCT01296477) | American Academy of Family Physicians | 2010-12-01 |
| A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO) (NCT01196039) | Genentech, Inc. | 2010-12-01 |
| The Economic Burden of Asthma in Canada (NCT03243110) | University of British Columbia | 2010-12-01 |
| A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2) (NCT01258803) | Organon and Co | 2010-12-01 |
| AeroEclipse II Agreement (NCT01288482) | The Hospital for Sick Children | 2010-11-01 |
| Efficacy of TPI ASM8 During a 14-Day Allergen Challenge (NCT01158898) | Syntara | 2010-11-01 |
| Study of Treatment of Depression in Refractory Asthma (NCT01153165) | Liam Heaney | 2010-11-01 |
| Mouse Allergen and Asthma Intervention Trial (NCT01251224) | Johns Hopkins University | 2010-11-01 |
| Reduction of Asthma Exacerbation Rate in Children by Non-invasive Monitoring of Inflammatory Markers in Exhaled Breath (Condensate): the RASTER Study (NCT01239238) | Maastricht University Medical Center | 2010-11-01 |
| Health2010-14: Monitoring Biomarkers of Chronic Diseases in the General Population (NCT01038518) | Glostrup University Hospital, Copenhagen | 2010-11-01 |
| Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis (NCT01234909) | Medical College of Wisconsin | 2010-11-01 |
| GSK2190915 Pediatric Study (NCT01286844) | GlaxoSmithKline | 2010-11-01 |
| Effects of Lipoic Acid on Oxidative, Inflammatory and Functional Markers in Asthmatic Patients (NCT01221350) | Centro Universitario de Ciencias de la Salud, Mexico | 2010-11-01 |
| A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge Model (NCT01241422) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-11-01 |
| Improving Asthma Outcomes Through Cultural Competence Training for Physicians (NCT01251523) | University of Michigan | 2010-11-01 |
| Dietary Interventions in Asthma Treatment: Sprouts Study (NCT01183923) | Johns Hopkins University | 2010-11-01 |
| The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen (NCT01225549) | AstraZeneca | 2010-11-01 |
| Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma (NCT01225315) | Idorsia Pharmaceuticals Ltd. | 2010-11-01 |
| Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) (NCT01097694) | Brigham and Women's Hospital | 2010-11-01 |
| Usage, Usability & Effect on Adherence and Clinical Outcomes of Text Message Reminders for Adolescents With Asthma (NCT01253330) | Children's Hospital Medical Center, Cincinnati | 2010-11-01 |
| Pharmacogenetic of Salbutamol in Pediatric Asthma Crisis (NCT02195258) | Hôpital Necker-Enfants Malades | 2010-11-01 |
| Predicting Steroid Response Using Exhaled Nitric Oxide (NCT01308411) | University of Nottingham | 2010-11-01 |
| Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma. (NCT01233284) | Boehringer Ingelheim | 2010-11-01 |
| Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. (NCT01494610) | GlaxoSmithKline | 2010-10-25 |
| A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment. (NCT01266941) | GlaxoSmithKline | 2010-10-18 |
| A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma (NCT01199289) | Amgen | 2010-10-04 |
| Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler (NCT01213849) | GlaxoSmithKline | 2010-10-04 |
| A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing (NCT01218009) | Teva Branded Pharmaceutical Products R&D, Inc. | 2010-10-01 |
| Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma (NCT01210170) | University of Miami | 2010-10-01 |
| Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients (NCT01431924) | GlaxoSmithKline | 2010-10-01 |
| Effects of Plant Stanols on Immune Function in Asthma Patients (NCT01715675) | Maastricht University Medical Center | 2010-10-01 |
| Pharmacokinetics in Adolescents (NCT01196689) | AstraZeneca | 2010-10-01 |
| To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma (NCT01568762) | Novartis Pharmaceuticals | 2010-10-01 |
| A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmatic Adolescent and Adult Patients. (NCT01191424) | Chiesi Farmaceutici S.p.A. | 2010-10-01 |
| Community Healthcare for Asthma Management and Prevention of Symptoms (NCT02454192) | George Washington University | 2010-10-01 |
| A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function (NCT01287065) | GlaxoSmithKline | 2010-10-01 |
| Bronchial Challenge Test of Magnesium-treated Asthmatics (NCT01118923) | University of Aarhus | 2010-10-01 |
| A Computerized Asthma Management System in the Pediatric Emergency Department (NCT01070147) | Vanderbilt University Medical Center | 2010-10-01 |
| Myeloid Suppressors in Inflammation (NCT01224223) | University of South Florida | 2010-10-01 |
| Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma (NCT01200446) | Indiana University | 2010-10-01 |
| Effectiveness of Anthroposophic Speech Therapy in Patients With Asthma (NCT02501824) | University of Bern | 2010-10-01 |
| Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers (NCT01216384) | Boehringer Ingelheim | 2010-10-01 |
| A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A (NCT01318980) | GlaxoSmithKline | 2010-09-30 |
| Oral GW766944 (Oral CCR3 Antagonist) (NCT01160224) | GlaxoSmithKline | 2010-09-08 |
| Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease (NCT01192360) | The Hospital for Sick Children | 2010-09-01 |
| Inhaled Iloprost in Mild Asthma (NCT01209533) | Vanderbilt University | 2010-09-01 |
| Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia (NCT01114906) | AstraZeneca | 2010-09-01 |
| Repeat Dose Safety Study for Compound to Treat Asthma (NCT01202214) | Accenture | 2010-09-01 |
| Use of Vitamin D3 for the Treatment of Steroid Resistant Asthmatic Patients (NCT01210521) | Florida Atlantic University | 2010-09-01 |
| Development of Cockroach Immunotherapy by the Inner-City Asthma Consortium (NCT01221285) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Study of Asthma and Nasal Steroids (NCT01118312) | JHSPH Center for Clinical Trials | 2010-09-01 |
| Prognostic Indicators as Provided by the EPIC ClearView (NCT01476995) | Epic Research & Diagnostics, Inc. | 2010-09-01 |
| Seasonal Allergic Rhinitis Study (NCT01123252) | University of East Anglia | 2010-09-01 |
| Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age (NCT01156792) | GlaxoSmithKline | 2010-09-01 |
| A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy (NCT01136655) | AstraZeneca | 2010-09-01 |
| A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval. (NCT01721135) | GlaxoSmithKline | 2010-09-01 |
| Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma (NCT01181895) | GlaxoSmithKline | 2010-09-01 |
| Effect of Allergen Challenge on Inflammation Induced by Toll-like Receptor Stimulation in a Nasal Model (NCT01204060) | McMaster University | 2010-09-01 |
| Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics (NCT01165138) | GlaxoSmithKline | 2010-08-20 |
| Distance Education Versus Usual Care Qualification in Asthma Care (NCT01595971) | Hospital de Clinicas de Porto Alegre | 2010-08-12 |
| Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients (NCT01176747) | Chiesi Farmaceutici S.p.A. | 2010-08-01 |
| Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I (NCT01172808) | Boehringer Ingelheim | 2010-08-01 |
| Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects (NCT01453296) | GlaxoSmithKline | 2010-08-01 |